Physician profile
Scott D Simon
NPI 1841237955
$2,962.91
in general payments reported to CMS, 2019-2025
38 companies · $476 in 2025
The $476 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $415 · 2021: $455 · 2022: $495 · 2023: $180 · 2024: $383 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.50 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $481.72 | 2019-2024 | Myrbetriq |
| Boston Scientific Corporation | $436.10 | 2019-2025 | Rezum Generator |
| Myriad Genetic Laboratories, INC. | $195.54 | 2021-2024 | Prolaris |
| Antares Pharma, INC. | $191.78 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $191.31 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $143.57 | 2019-2025 | |
| Abbvie INC. | $110.59 | 2024-2025 | |
| Allergan, INC. | $95.63 | 2019-2020 | |
| Convatec INC. | $91.56 | 2019-2022 | |
| Axonics, INC. | $82.80 | 2021-2024 | Axonics |
| Neotract INC. | $74.53 | 2019-2020 | |
| Urogen Pharma, INC. | $67.39 | 2025 | |
| 180 Medical, INC. | $63.06 | 2020-2023 | Gentlecath |
| Immunitybio, INC. | $54.81 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $48.71 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $46.53 | 2021 | |
| Urovant Sciences INC | $44.77 | 2022 | |
| Janssen Biotech, INC. | $39.77 | 2022 | |
| Dentsply Ih INC. | $38.99 | 2019 | |
| Hollister Incorporated | $36.26 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Ferring Pharmaceuticals INC. | $32.55 | 2019-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $31.25 | 2025 | Trelstar |
| Dendreon Pharmaceuticals LLC | $30.32 | 2020 | |
| Tolmar, INC. | $27.92 | 2023-2024 | |
| Accord Healthcare, INC. | $25.92 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $24.06 | 2025 | Bard Urinary Drainage Bag |
| Teleflex LLC | $23.89 | 2023 | Urolift |
| Acerus Pharmaceuticals Corporation | $23.76 | 2020 | |
| Alexion Pharmaceuticals, INC. | $23.61 | 2019 | |
| Merck Sharp & Dohme LLC | $23.16 | 2020 | |
| Olympus America INC. | $21.83 | 2020 | |
| Medtronic, INC. | $19.76 | 2021 | |
| Abc Home Medical Supply, INC. | $18.85 | 2022 | |
| Endo USA, INC. | $18.02 | 2025 | Xiaflex |
| Halozyme INC | $17.48 | 2023 | |
| Biotissue Holdings INC. | $15.50 | 2025 | |
| Sagent Pharmaceuticals | $14.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.